Clinical Trial Update: An Observational, Prospective, Safety Study of Mircera (Monopegylated Epoetin Beta) in Clinical Practice

View source ↗

Summary

This clinical trial update reports results from a completed observational safety study of Mircera (monopegylated epoetin beta) in patients with chronic kidney d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Kidney Disease, Chronic | Status: COMPLETED | Results posted: 2016-07-28